Lung cancer registry that tracks patient information
Part of Cancer, Lungs & breathing clinical trials.
This trial is a registry that collects information from people with certain types and stages of lung cancer. It helps researchers understand how these cancers are managed in real life, which can guide better future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must have non-small cell lung cancer (NSCLC) in stages IIIA, IIIB, IIIC, or IVA or IVB
- Or you must have small cell lung cancer (SCLC) that is either limited disease (LD) or extensive disease (ED)
- This is a registry study, so it is mainly about sharing data rather than taking a study drug
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people having surgery to remove a small part of the lung (segmentectomy) for early-stage lung cancer. It helps doctors learn more about this surgery and its outcomes.
This study helps hospitals use the latest lung cancer guidelines better. If you have NSCLC or ES-SCLC and haven't had recent treatment, this trial may help improve the quality of care you receive.
This study is looking back at the medical records of people with early-stage non-small cell lung cancer who had surgery or radiation therapy between 2018 and 2019. The goal is to understand how patients were diagnosed and treated, which may help improve care for others in the future.
This study is for people diagnosed with lung cancer at a younger age (under 50). It aims to understand your needs and improve care through a dedicated program. You will be asked to complete surveys about your experience.
This trial looks at information and tissue from people with stage I to stage IIIA non-small cell lung cancer (NSCLC) who have surgery, sometimes with chemotherapy before surgery. Researchers want to understand why cancers come back (resistance) and how to better target treatments later.
This study collects real-world information about people with lung cancer who get newer kinds of cancer drugs. It aims to understand how these innovative therapies work in everyday care and help future research.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.